semaglutide patent expiry india weight-loss drug has expired in India, Indian pharmaceutical has wasted no-time to announce generics. What is the most pressing concern about semaglutide generics in India? ✅️Use without prescription is risky Novo Nordisk patent expiry sparks

The brand makes some bold health claims, but are they legit?

Over the past year, Ive seen a growing number of patients achieving remarkable weight-loss success with GLP-1 medications

Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk

It is the best weight management supplement to support an active lifestyle and any healthy diet program

Semaglutide dosing typically starts at 0.25 mg weekly and escalates every 4 weeks

Active Ingredient Semaglutide (Advanced GLP-1 Receptor Agonist) Cartridge Concentration 15 mg Semaglutide per 3ml Cartridge (5 mg/mL) Delivery Tool Semaglyn Reusable Customized Precision Injector Pen Primary Manufacturer Zydus Healthcare Limited Administration Route Subcutaneous Injection (Weekly adjustable baseline) Kit Components 1 Cartridge + 1 Reusable Pen + 10 Sterile Needles Primary Indication Chronic Anti-Obesity Management & Type 2 Diabetes Support